SINCLAIR
Sinclair Pharma, headquartered in London, UK, is an international leader in the aesthetics industry. Founded in 1971, Sinclair has built a strong portfolio of differentiated, complementary aesthetic technologies designed to meet clinical needs for effective, high-quality, long-duration, and minimally-invasive treatments. The company offers a range of products, including well-known brands like Silhouette Soft, Ellansé, Perfectha, and MaiLi, which are utilized for facial rejuvenation and contouring. These products focus on collagen stimulation to deliver natural-looking results with minimal downtime. Sinclair's innovations extend beyond injectables to energy devices such as Cooltech, Elysion, and Préime DermaFacial, further broadening their impact in the aesthetic market. Since being acquired by Huadong Medicine in 2018, Sinclair has expanded its global footprint, particularly in Europe, Brazil, Mexico, and South Korea, with plans to enter new geographic markets and introduce new product lines in the coming years. The company's commitment to quality and innovation is supported by extensive research and development, making it a trusted partner for aesthetic professionals worldwide.
SINCLAIR Introduction
Founded in 1971, Sinclair Pharma is a global medical aesthetics organization. The company delivers a unique range of scientifically advanced aesthetic collagen stimulation products for facial volume loss, thread lifting for facial contouring and dermal fillers for wrinkles and lines, made exclusively for a worldwide clinicians’ industry, ensuring our community has real, long-lasting, exceptional results thus transforming confidence and appearance, every time. With an in-house commercial infrastructure, including manufacturing and a network of distributors in leading global markets, our products are sold in 55 countries worldwide. Sinclair was acquired by Huadong Medicine Ltd in 2018.